Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Incyte Stock: Is Wall Street Bullish or Bearish?

Valued at $14.5 billion by market cap, Incyte Corporation (INCY) is a biopharmaceutical company specializing in innovative treatments for hematology/oncology and autoimmune diseases. Based in Wilmington, Delaware, the company's portfolio includes notable treatments like Jakafi and Monjuvi, addressing a range of complex medical conditions.

Shares of this specialty drugmaker have underperformed the broader market over the past 52 weeks. INCY has risen marginally during this period, contrasting with the S&P 500 Index's ($SPX) robust rally of 28.1%. In 2024, INCY shares are up 2.5%, lagging behind SPX's 17.3% gain on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.